Categories Earnings, LATEST

Winnebago Industries (NYSE: WGO): Q1 2020 Earnings Snapshot

— Winnebago Industries Inc. (NYSE: WGO) reported its first-quarter 2020 earnings of $0.44 per share and adjusted earnings of $0.73 per share. This is compared to the analysts’ expectations of $0.57 per share.

— Revenues jumped by 19% to $588.5 million versus $538.89 million expected.

Earnings Update by AlphaStreet

— Excluding the recently acquired Newmar business, revenue increased by 12% on an organic basis to $552.8 million driven by strong growth in the Towable segment and modest growth in the Motorhome business.

— Revenues for the Towable segment grew 17% to $341.3 million, riding on strong unit growth in the Grand Design RV product line.

— Revenues from the Motorhome segment jumped by 25% to $225.9 million, primarily driven by strength in the Class B line-up and the addition of Newmar revenues. Excluding Newmar, segment revenues grew 5% over the prior-year period.

— On December 18, the company’s board of directors approved a quarterly cash dividend of $0.11 per share, payable on January 29, 2020, to common stockholders of record on January 15, 2020.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Also Read:  Biocept (BIOC) revenue drops 23% in Q2; loss narrows

Most Popular

Baidu (BIDU) Q2 earnings rise unexpectedly; stock falls

https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the

Applied Materials (AMAT) tops Q3 2020 targets; provides Q4 outlook

Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies

Top